Delivery Order SPE2DB22D1017-SPE2DB23FF9HV

Award Date 6/30/23
Potential Completion Date 7/3/23
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $1,652 by the Defense Logistics Agency to provide 4561707977 CYCLOSPORINE 0.05% EYE EMULS 30S. The contract has a period of performance from August 4-7, 2023. Under the terms of the firm fixed price delivery order, Amerisourcebergen will supply the specified pharmaceutical to locations in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $13,788.27 firm fixed price delivery order by the Defense Logistics Agency to supply 4561822453 CYCLOSPORINE 0.05% EYE EMULS 30S. The single day contract has a period of performance from August 15, 2023 through August 16, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,194.31 firm fixed price delivery order by the Defense Logistics Agency to supply 4562141542 CYCLOSPORINE 0.05% EYE EMULS 30S. The single day contract has a period of performance from September 12, 2023 through September 13, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,888.37 firm fixed price delivery order by the Defense Logistics Agency to supply 4561435008 CYCLOSPORINE 0.05% EYE EMULS 30S. The delivery order is being issued against an existing DLA contract vehicle and calls for Amerisourcebergen to deliver the specified pharmaceutical to a location in Conshohocken, Pennsylvania, with performance required between July 7-10, 2023. As the nation's largest...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,502.70 to supply 4563117596 CYCLOSPORINE 0.05% EYE EMULS 60S. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. Issued against an indefinite delivery contract with no set-aside designation, this order supports DLA Troop Support Medical's provision of pharmaceuticals and...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a six hundred thirty-two dollar firm fixed price delivery order contract from the Defense Logistics Agency Troop Support Medical to supply CYCLOSPORINE 0.05% EYE EMULS 30S. The place of performance will be in Conshohocken, Pennsylvania, with an anticipated completion date of October 23, 2023. No set-aside designation was applied to this award to fulfill the Defense Logistics Agency's medical supply...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has received a $2,631.77 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply CYCLOSPORINE 0.05% EYE EMULS 60S. The order was awarded on November 30, 2023 under the company's existing contracts with no set-aside designation specified. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December 1, 2023. As a...
The Defense Logistics Agency awarded a $2,606.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561345021 CYCLOSPORINE 0.05% EYE EMULS 30S. The place of performance is Conshohocken, Pennsylvania. The period of performance is June 26-27, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will deliver the requested cyclosporine ophthalmic emulsion to support the Defense Logistics Agency's medical supply needs. No major...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $1,422 against the Defense Logistics Agency's prime vendor pharmaceutical contract to supply 60 units of 0.05% cyclosporine ophthalmic emulsion. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania over a period of 3 days from July 7 through July 10, 2023. Pricing is firm fixed. No subcontractors or set aside designations...
<p>Amerisourcebergen Drug Corp was awarded a six-hundred-seventeen dollar firm fixed price delivery order for CYCLOSPORINE 0.05% EYE EMULS 30S under the Defense Logistics Agency's pharmaceutical products contract vehicle. The delivery order has a period of performance through October 16, 2023 for product delivery to a location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award to supply the Defense Logistics Agency with the specified pharmaceutical item.</p>
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB23FF9HV
    Delivery Order

Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $2,776.05 delivery order contract by the Defense Logistics Agency to supply 4561391674 CYCLOSPORINE 0.05% EYE EMULS 30S. The firm fixed price contract is for product delivery by July 3, 2023 with performance taking place in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency utilizes contracts such as this to efficiently procure pharmaceuticals in support of the military health system and readiness needs of the Department of Defense.

Generated 12/22/23, 7:45 PM